cr-001
·Code: SKB118
cr-001: 1 clinical trial tracked.
cr-001 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about cr-001, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Primary endpoint: Dose Escalation - Incidence and nature of dose-limiting toxicities
Interventionalopen290 targetStarted 2026-02Completion 2029-0231 sites · Australia, Ireland, Italy, Romania…Crescent Biopharma, Inc.